You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海正藥業(600267.SH):雲南生物製藥重整計劃獲法院裁定批准
格隆匯 12-23 16:59

格隆匯12月23日丨海正藥業(600267.SH)公佈,雲生公司第一次債權人會議於2020年12月17日召開,對《雲南生物製藥有限公司重整計劃草案》進行表決。其中,職工債權組、小額債權組(債權金額10萬元及以下)權益未受到調整,不對《重整計劃草案》進行表決;普通債權組和出資人組均表決通過了《重整計劃草案》。

根據《中華人民共和國企業破產法》第八十六條的規定,管理人於2020年12月21日向昆明中院提交了裁定批准雲生公司重整計劃的申請。2020年12月23日,管理人收到了昆明中院送達的(2020)雲01破10號之一《民事裁定書》,裁定批准雲生公司重整計劃,並終止雲生公司重整程序。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account